Advances in Differentiated Service Delivery (DSD) and antiretroviral drug optimization in Zimbabwe have made HIV care and treatment more acceptable and effective, leading to greater coverage and better health outcomes—especially for patients with advanced or unstable HIV.
With an in-depth understanding of the status of the national HIV epidemic through the Zimbabwe Population-based HIV Impact Assessment (ZIMPHIA) surveys conducted in 2016 and 2020, ICAP has continued working to improve service quality, strengthen human resources for health, and build capacity in epidemiology and strategic information (SI) for evidence-based HIV programs, policy and response.
Optimizing Differentiated Service Delivery for People Living with HIV (PLHIV) in Urban Zimbabwe: Assessing urban PLHIV preferences for treatment delivery models using a discrete choice experimentDistricts (or national):Harare
ICAP in Zimbabwe
Key Technical Areas
- Capacity Building of Health Workforce
- DREAMS (Women’s HIV Prevention)
- Health Information Systems
- Key / Priority Populations
- Implementation Science / Operations Research
- Laboratory Support
- Monitoring & Evaluation / SI
- Recency Testing
- Treatment Optimization
Bill & Melinda Gates Foundation
U.S. President’s Emergency Program for AIDS Relief (PEPFAR) / Centers for Disease Control and Prevention (CDC)
PEPFAR / Health Resources & Services Administration (HRSA)
Wits Reproductive Health Initiative
Godfrey Musuka, DVM, Msc(Med), MPhil, PhD
Godfrey Musuka is ICAP’s Country Director in Zimbabwe. He is an HIV/AIDS M&E and public health expert with 25 years of experience implementing health interventions in Zimbabwe, Botswana, and Nigeria. He has worked for UNICEF, ACHAP (the partnership between the Government of Botswana, the Gates Foundation, Merck & the Merck Company Foundation) in the areas of HIV/AIDS, TB, and immunization. His key areas of interest include strategic information and program management. Godfrey holds the following qualifications DVM, MSc(Med), MPhil, PhD.